PFBT
EWTX icon

Parkside Financial Bank & Trust’s Edgewise Therapeutics EWTX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1K Hold
35
– – ﹤0.01% 2324
2025
Q4 		$869 Hold
35
– – ﹤0.01% 2385
2025
Q3 		$569 Hold
35
– – ﹤0.01% 2511
2025
Q2 		$459 Sell
35
-5
-13% -$72 ﹤0.01% 2591
2025
Q1 		$880 Buy
+40
New +$1.05K ﹤0.01% 2155

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Parkside Financial Bank & Trust's EWTX Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Edgewise Therapeutics (EWTX) position steady in Q1 2026 at 35 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2324.

Parkside Financial Bank & Trust first reported a position in EWTX in Q1 2025 and has held it in 5 quarters since. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Parkside Financial Bank & Trust held 35 shares of Edgewise Therapeutics worth $1.1K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Edgewise Therapeutics share count unchanged in Q1 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2324 holding.
  • Parkside Financial Bank & Trust first reported a position in Edgewise Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.